Zhejiang Orient Gene Biotech Co., Ltd. (688298.SS)

CNY 29.1

(-2.68%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 8.99 Billion 10.7 Billion 8.97 Billion 3.57 Billion 361.51 Million 337.64 Million
Total Current Assets 5.89 Billion 8.74 Billion 8.12 Billion 3.31 Billion 259.68 Million 243.71 Million
Cash And Short Term Investments 5.21 Billion 7.75 Billion 6.26 Billion 2.23 Billion 85.43 Million 102.55 Million
Cash and Cash Equivalents 4.16 Billion 6.59 Billion 6.09 Billion 2.03 Billion 85.43 Million 102.55 Million
Short Term Investments 1.05 Billion 1.16 Billion 168.06 Million 199 Million - -
Net Receivables 302.04 Million 445.39 Million 1.35 Billion 699.36 Million 90.12 Million 64.89 Million
Inventory 346.77 Million 431.91 Million 470.56 Million 381.57 Million 77.96 Million 75.53 Million
Other Current Assets 30.4 Million 112.51 Million 33.82 Million 780.68 Thousand 6.15 Million 741.53 Thousand
Total Non-Current Assets 3.09 Billion 1.95 Billion 850.54 Million 253.88 Million 101.82 Million 93.92 Million
Net PPE 2.28 Billion 1.07 Billion 481.33 Million 162.39 Million 77.87 Million 48.18 Million
Good Will And Intangible Assets 478.81 Million 457.99 Million 126.89 Million 14.13 Million 14.61 Million 9.82 Million
Good Will - - 15.41 Million - - -
Intangible Assets 478.81 Million 457.99 Million 111.47 Million 14.13 Million 14.61 Million 9.82 Million
Long-Term Investments 52.35 Million -1.12 Billion -142.61 Million 5.08 Million 4.48 Million 28.88 Million
Tax Assets 218.25 Million 193.23 Million 69.68 Million 45.45 Million 4.77 Million 4.1 Million
Other Non Current Assets 61.05 Million 1.35 Billion 315.24 Million 26.82 Million 69 Thousand 2.92 Million
Other Assets -0.00 - - - 1.00 -
Total Liabilities 1.43 Billion 2.38 Billion 2.08 Billion 1.12 Billion 107.38 Million 129.61 Million
Total Current Liabilities 1.08 Billion 2.27 Billion 2.05 Billion 1.11 Billion 91.51 Million 121.26 Million
Account Payables 574.72 Million 1.58 Billion 1.17 Billion 371.97 Million 49.15 Million 48.6 Million
Tax Payables 3.77 Million 86.47 Million 655.25 Million 350.48 Million 3.33 Million 9.66 Million
Short Term Debt 353 Million 3.55 Million 5.83 Million 2.37 Million 20.43 Million 50 Million
Deferred Revenue 34.76 Million 339.13 Million 877.23 Million 325.69 Million 16.9 Million 9.66 Million
Other Current Liabilities 123.29 Million 355.72 Million 1.76 Million 412.95 Million 5.02 Million 12.99 Million
Total Non Current Liabilities 349.97 Million 102.26 Million 29.66 Million 8.8 Million 15.86 Million 8.35 Million
Long-Term Debt 300 Million 78.64 Million 12.65 Million 2.83 Million 6.56 Million -
Deferred Revenue Non Current 286.17 Thousand 14.16 Million 14.81 Million 8.8 Million 9.29 Million 8.35 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 49.65 Million 6.68 Million 2.2 Million -2.83 Million 6.56 Million -
Other Liabilities 1.00 - 1.00 1.00 - -
Total Equity 7.54 Billion 8.32 Billion 6.88 Billion 2.45 Billion 254.12 Million 208.02 Million
Stock Holders Equity 7.43 Billion 8.16 Billion 6.85 Billion 2.44 Billion 251.72 Million 201.03 Million
Common Stock 201.6 Million 168 Million 120 Million 120 Million 90 Million 90 Million
Retained Earnings 6.71 Billion 7.44 Billion 6.14 Billion 1.72 Billion 114.87 Million 72.34 Million
Accumulated other comprehensive income 128.46 Million 112.66 Million 50.57 Million 55.53 Million 21.76 Million 38.68 Million
Common Stock Equity 7.43 Billion 8.16 Billion 6.85 Billion 2.44 Billion 251.72 Million 201.03 Million
Capital Lease Obligation 43.95 Million 28.64 Million 12.65 Million 2.83 Million - -
Total Investments 1.1 Billion 35.58 Million 25.45 Million 199 Million 4.48 Million 28.88 Million
Total Debt 696.95 Million 82.19 Million 18.48 Million 5.21 Million 27 Million 50 Million
Net Debt -3.46 Billion -6.51 Billion -6.07 Billion -2.03 Billion -58.43 Million -52.55 Million

Balance Sheet Charts